StockData
Amgen Inc logo

Amgen Inc (AMGN) operating KPIs

AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$466.01+5.28 (+1.15%)

Close on Oct 30, 2026Market cap $251.94BP/E 28.9Yield 2.07%

Amgen r&D Expense by Stage (10-K MD&A) — Total R&D Expense ($M) ($M)

Form 10-Q / 10-K Consolidated Statements of Income & MD&A R&D by Category

QuarterlyAnnual
Latest, Q2 2026
1,868
Period ended Jun 30, 2026
Change on a year earlier
+7.1%
1,744 in Q2 2025
History
46 quarters
Since Q1 2015
Sources
36
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedR&D Expense by Stage (10-K MD&A) — Total R&D Expense ($M) ($M)Year on yearSource
Q2 2026Jun 30, 20261,868+7.1%Form 10-Q (filed 2026-08-05) ↗
Q1 2026Mar 31, 20261,719+15.7%Form 10-Q (filed 2026-05-01) ↗
Q4 2025Dec 31, 20252,142+24.2%Form 10-K (filed 2026-02-13) ↗
Q3 2025Sep 30, 20251,900+31.0%Form 10-Q (filed 2025-11-05) ↗
Q2 2025Jun 30, 20251,744+20.5%Form 10-Q (filed 2026-08-05) ↗
Q1 2025Mar 31, 20251,486+10.6%Form 10-Q (filed 2026-05-01) ↗
Q4 2024Dec 31, 20241,724+12.4%Form 10-K (filed 2026-02-13) ↗
Q3 2024Sep 30, 20241,450+34.4%Form 10-Q (filed 2025-11-05) ↗
Q2 2024Jun 30, 20241,447+30.0%Form 10-Q (filed 2025-08-06) ↗
Q1 2024Mar 31, 20241,343+26.9%Form 10-Q (filed 2025-05-02) ↗
Q4 2023Dec 31, 20231,534+15.9%Form 10-K (filed 2026-02-13) ↗
Q3 2023Sep 30, 20231,079-3.0%Form 10-Q (filed 2024-10-31) ↗
Q2 2023Jun 30, 20231,113+7.1%Form 10-Q (filed 2024-08-07) ↗
Q1 2023Mar 31, 20231,058+10.3%Form 10-Q (filed 2024-05-03) ↗
Q4 2022Dec 31, 20221,324-1.8%Form 10-K (filed 2025-02-14) ↗
Q3 2022Sep 30, 20221,112-21.8%Form 10-Q (filed 2023-10-31) ↗

Breakdown

What makes up r&d expense by stage (10-k md&a) — total r&d expense ($m)

Cite this data

StockData. (2026). Amgen R&D Expense by Stage (10-K MD&A) — Total R&D Expense ($M) ($M), quarterly Q1 2015–Q2 2026 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/rd_cat_tot

See every metric in the Amgen KPI table. Data updated Oct 28, 2026.